” The forthcoming article in JLME also presents systematic, quantitative evidence that since the industry started making large contributions to the FDA for reviewing its drugs, as it makes large contributions to Congressmen who have promoted this substitution for publicly funded regulations, the FDA has sped up the review process with the result that drugs approved are significantly more likely to cause serious harm, hospitalizations, and deaths. ”
Read Is the FDA being compromised by Pharma Payments?
by John LaMattina, Forbes, 8/07/2013.
Related post: Institutional Corruption of Pharmaceuticals, the Myth of safe and effective Drugs, 1 June 2013.